rs202175449
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_000438.6(PAX3):āc.643A>Gā(p.Ser215Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000303 in 1,611,416 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_000438.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAX3 | NM_181458.4 | c.586+57A>G | intron_variant | ENST00000392070.7 | NP_852123.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAX3 | ENST00000392070.7 | c.586+57A>G | intron_variant | 1 | NM_181458.4 | ENSP00000375922.3 |
Frequencies
GnomAD3 genomes AF: 0.00160 AC: 243AN: 152246Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000409 AC: 102AN: 249652Hom.: 1 AF XY: 0.000341 AC XY: 46AN XY: 134946
GnomAD4 exome AF: 0.000168 AC: 245AN: 1459052Hom.: 1 Cov.: 36 AF XY: 0.000161 AC XY: 117AN XY: 725436
GnomAD4 genome AF: 0.00160 AC: 244AN: 152364Hom.: 0 Cov.: 32 AF XY: 0.00150 AC XY: 112AN XY: 74514
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 23, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 07, 2020 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 23, 2015 | p.Ser215Gly in exon 4A of PAX3: This variant is not expected to have clinical si gnificance because it has been identified in 0.6% (56/10348) of African chromoso mes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; d bSNP rs202175449). In addition, this amino acid position is not conserved acros s species with most other species (including mammals) having a glycine (Gly) at amino acid position 215. - |
PAX3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 15, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at